ABBV · Categories · Coverage
ABBV - Analyst coverage initiated
AbbVie Inc. (ABBV) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for ABBV
- Canaccord Genuity initiated coverage on AbbVie with a new price targetCanaccord Genuity initiated coverage of AbbVie with a rating of Buy and set a new price target of $262.00
- RBC Capital Mkts initiated coverage on AbbVie with a new price targetRBC Capital Mkts initiated coverage of AbbVie with a rating of Outperform and set a new price target of $260.00
- Barclays initiated coverage on AbbVie with a new price targetBarclays initiated coverage of AbbVie with a rating of Overweight and set a new price target of $275.00
- Scotiabank initiated coverage on AbbVie with a new price targetScotiabank initiated coverage of AbbVie with a rating of Sector Outperform and set a new price target of $280.00
- Cantor Fitzgerald initiated coverage on AbbVie with a new price targetCantor Fitzgerald initiated coverage of AbbVie with a rating of Overweight and set a new price target of $210.00
- Wolfe Research initiated coverage on AbbVie with a new price targetWolfe Research initiated coverage of AbbVie with a rating of Outperform and set a new price target of $205.00
- Bernstein initiated coverage on AbbVie with a new price targetBernstein initiated coverage of AbbVie with a rating of Mkt Perform and set a new price target of $203.00
- Cantor Fitzgerald initiated coverage on AbbVie with a new price targetCantor Fitzgerald initiated coverage of AbbVie with a rating of Overweight and set a new price target of $200.00
- Deutsche Bank initiated coverage on AbbVie with a new price targetDeutsche Bank initiated coverage of AbbVie with a rating of Hold and set a new price target of $150.00
- Raymond James initiated coverage on AbbVie with a new price targetRaymond James initiated coverage of AbbVie with a rating of Outperform and set a new price target of $177.00
- William Blair initiated coverage on AbbVieWilliam Blair initiated coverage of AbbVie with a rating of Mkt Perform
- HSBC Securities initiated coverage on AbbVie with a new price targetHSBC Securities initiated coverage of AbbVie with a rating of Buy and set a new price target of $167.00
- Guggenheim initiated coverage on AbbVie with a new price targetGuggenheim initiated coverage of AbbVie with a rating of Buy and set a new price target of $172.00
- Credit Suisse initiated coverage on AbbVie with a new price targetCredit Suisse initiated coverage of AbbVie with a rating of Outperform and set a new price target of $170.00
- SVB Leerink initiated coverage on AbbVie with a new price targetSVB Leerink initiated coverage of AbbVie with a rating of Underperform and set a new price target of $140.00
- Redburn initiated coverage on AbbVieRedburn initiated coverage of AbbVie with a rating of Buy
- Goldman Sachs initiated coverage on AbbVie with a new price targetGoldman Sachs initiated coverage of AbbVie with a rating of Neutral and set a new price target of $113.00